Bristol-Myers Squibb Company (
) has announced an ex-dividend date of January 02, 2013 and a cash
dividend payment of $0.35 per share scheduled for February 01,
2013. Shareholders who purchased BMY stock prior to the ex-dividend
date are eligible for the cash dividend payment. This represents an
2.94% increase over the prior quarter.
The previous trading day's last sale of BMY was $32.14,
representing a -11.56% decrease from the 52 week high of $36.34 and
a 4.9% increase over the 52 week low of $30.64.
BMY is a part of the Consumer Durables sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). BMY's current earnings per share, an indicator of a company's
profitability, is $1.09. Zacks Investment Research reports BMY's
forecasted earnings growth in 2012 as -13.94%, compared to an
industry average of .4%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to BMY through an Exchange
Traded Fund [ETF]?
The following ETF(s) have BMY as a top-10 holding:
- iShares Dow Jones U.S. Pharmaceutical Index Fund (
- PowerShares Dynamic Pharmaceuticals (
- Merrill Lynch Pharmaceutical HOLDRS (
- Select Sector SPDR Fund - Health Care (
- Columbia Concentrated Large Cap Value Strategy Fund (
The top-performing ETF of this group is GVT with an increase of
10.22% over the last 100 days. IHE has the highest percent
weighting of BMY at 5.83%.